万维提示：
1、投稿方式：在线投稿。
2、期刊网址：https://www.clinicaloncologyonline.net/
https://www.journals.elsevier.com/clinical-oncology/
3、投稿网址：https://www.editorialmanager.com/YCLON
4、官网邮箱：clinonc@editorialoffice.co.uk
5、期刊刊期：月刊，一年出版十二期。
2021年5月21日星期五
投稿须知【官网信息】
Guide for Authors
Papers must be submitted exclusively to the Journal via https://www.editorialmanager.com/yclon on the understanding that they have not been and will not be published elsewhere.
The main author is responsible for ensuring that the article has been seen and approved by all the other authors. It is the authors' responsibility to obtain and supply written permission for the reproduction of any tables, illustrations, or quotations of more than 25 words that have been published elsewhere. Authors must describe any direct or indirect financial interest they have in the subject matter of a submitted manuscript. Papers accepted by the Journal become the copyright of the Royal College of Radiologists. Authors should notify the Editorial Office if there is any reason (e.g. Crown copyright or other restrictions) why they may not be able to transfer copyright to the Royal College of Radiologists. This Journal supports the COPE Guidelines for publication in Medical Research. Refer to Clinical Oncology 2000;12:206-212.
All papers accepted for publication in Clinical Oncology will appear on our online platforms. The Editor in Chief will decide which accepted papers will appear in the print version of the Journal.
Online Submission
Our online submission system guides you stepwise through the process of entering your article details and uploading your files. The system converts your article files to a single PDF file used in the peer-review process. Editable files (e.g., Word, LaTeX) are required to typeset your article for final publication. All correspondence, including notification of the Editor's decision and requests for revision, is sent by e-mail.
Order of Submission
Your Article files must be submitted online in the following order: Covering Letter; Title Page; Research Highlights (for original articles); Statement of Searches (for overview articles); Abstract (including key words); Manuscript (including reference list and acknowledgement); Figures; Tables; Supplementary Material; Permission agreement (if necessary); Conflict of Interest Statement.
Editors
Authors from Australia, New Zealand, Singapore, Malaysia, and Hong Kong, must submit their manuscripts to the Regional Editor for Australasia. Authors from the US and Canada must submit their manuscripts to the Regional Editor for North America. Authors from India, China, and all other countries in Asia must submit their manuscripts to the Regional Editor for Asia. Authors from the UK, and all other countries in Europe must submit their manuscripts to the Editor-in-Chief.
Contact Details:
Direct your queries to the Editorial Office: email: clinonc@editorialoffice.co.uk.
Original Articles and Overview Articles
Original Articles and Overview Articles must keep to a strict word limit of 3,500 words, excluding References and Title Page. Statistical Methods should be defined in the Methods section of the paper, and any not in common use should be either described in detail or supported by references. Refer to Clinical Oncology 2000;12:202-205. For Overview Articles the abstract must be prefaced by a statement detailing the search strategies used and sources of information.
Editorials
Editorials must be no more than 1,500 words in length and relate to articles published in the Journal, or to issues of relevance for the readership. Editorials are normally solicited by the Editor and Assistant Editor, and authors should discuss other proposals with the Editor prior to submission.
Meetings' Abstracts
Proposals for submitting Meetings' Abstracts should be addressed to the Editor before submission of the Abstracts. Meetings' Abstracts may be considered for publication as part of our page budget within an Issue of the Journal, or as a separate Abstracts Book of the Journal for which the organisers will be charged. They should be structured to include clear sections describing the aim of the project, method used, results and conclusions, and should contain adequate data to assess the results and interpret the conclusions. It is not sufficient to state in the results' section that "data will be presented" or similar phrasing, and descriptive accounts of work in progress will not be considered for publication. All the Meetings' abstracts must be submitted in a single File with each Abstract starting on a separate page. A title page must be provided, listing the full name of the meeting, date and venue at which the Abstracts were presented. If the Abstracts are grouped together under specific topics, a content page must be provided, listing the topics, the title of the abstracts, the name of the authors, and the abstract number, in the order in which they are to appear in the Journal. If a full contents page, listing - e.g. the dates of the various sessions, session number, title of session, title of abstract, authors' name, abstract number - is required, this must be provided at the same time as the abstracts. The standard format for an Abstract is, Title of Abstract, Authors' names (initials followed by surname - no title), Institute/Hospital, Purpose, Methods, Results, Conclusion.
Revised Manuscripts
Authors are requested to submit 2 copies of their Revised Manuscripts; one clean copy and one copy highlighting the changes made.
Correspondence to the Editor
Letters will be published if they are deemed of sufficient interest and relevance. Priority will be given to letters relating to articles previously published in the Journal, but also including other comment on matters of interest to oncologists. Letters should be no longer than 300 words.
Editorial Office: email: clinonc@editorialoffice.co.uk.
Submission checklist
You can use this list to carry out a final check of your submission before you send it to the journal for review. Please check the relevant section in this Guide for Authors for more details.
Ensure that the following items are present:
One author has been designated as the corresponding author with contact details:
• E-mail address
• Full postal address
All necessary files have been uploaded:
Manuscript:
• Include keywords
• All figures (include relevant captions)
• All tables (including titles, description, footnotes)
• Ensure all figure and table citations in the text match the files provided
• Indicate clearly if color should be used for any figures in print
Graphical Abstracts / Highlights files (where applicable)
Supplemental files (where applicable)
Further considerations
• Manuscript has been 'spell checked' and 'grammar checked'
• All references mentioned in the Reference List are cited in the text, and vice versa
• Permission has been obtained for use of copyrighted material from other sources (including the Internet)
• A competing interests statement is provided, even if the authors have no competing interests to declare
• Journal policies detailed in this guide have been reviewed
• Referee suggestions and contact details provided, based on journal requirements
Ethics in publishing
Please see our information pages on Ethics in publishing and Ethical guidelines for journal publication.
Studies in humans and animals
If the work involves the use of human subjects, the author should ensure that the work described has been carried out in accordance with The Code of Ethics of the World Medical Association (Declaration of Helsinki) for experiments involving humans. The manuscript should be in line with the Recommendations for the Conduct, Reporting, Editing and Publication of Scholarly Work in Medical Journals and aim for the inclusion of representative human populations (sex, age and ethnicity) as per those recommendations. The terms sex and gender should be used correctly.
Authors should include a statement in the manuscript that informed consent was obtained for experimentation with human subjects. The privacy rights of human subjects must always be observed.
All animal experiments should comply with the ARRIVE guidelines and should be carried out in accordance with the U.K. Animals (Scientific Procedures) Act, 1986 and associated guidelines, EU Directive 2010/63/EU for animal experiments, or the National Institutes of Health guide for the care and use of Laboratory animals (NIH Publications No. 8023, revised 1978) and the authors should clearly indicate in the manuscript that such guidelines have been followed. The sex of animals must be indicated, and where appropriate, the influence (or association) of sex on the results of the study.
Informed consent and patient details
Studies on patients or volunteers require ethics committee approval and informed consent, which should be documented in the paper. Appropriate consents, permissions and releases must be obtained where an author wishes to include case details or other personal information or images of patients and any other individuals in an Elsevier publication. Written consents must be retained by the author but copies should not be provided to the journal. Only if specifically requested by the journal in exceptional circumstances (for example if a legal issue arises) the author must provide copies of the consents or evidence that such consents have been obtained. For more information, please review the Elsevier Policy on the Use of Images or Personal Information of Patients or other Individuals. Unless you have written permission from the patient (or, where applicable, the next of kin), the personal details of any patient included in any part of the article and in any supplementary materials (including all illustrations and videos) must be removed before submission.
Declaration of competing interest
All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence (bias) their work. Examples of potential conflicts of interest include employment, consultancies, stock ownership, honoraria, paid expert testimony, patent applications/registrations, and grants or other funding. Authors should create a declaration of competing interest statement using this tool and upload to the submission system at the Attach Files step. Note: Please do not convert the .docx template to another file type. Author signatures are not required.
Submission declaration and verification
Submission of an article implies that the work described has not been published previously (except in the form of an abstract, a published lecture or academic thesis, see 'Multiple, redundant or concurrent publication' for more information), that it is not under consideration for publication elsewhere, that its publication is approved by all authors and tacitly or explicitly by the responsible authorities where the work was carried out, and that, if accepted, it will not be published elsewhere in the same form, in English or in any other language, including electronically without the written consent of the copyright-holder. To verify originality, your article may be checked by the originality detection service Crossref Similarity Check.
Use of inclusive language
Inclusive language acknowledges diversity, conveys respect to all people, is sensitive to differences, and promotes equal opportunities. Content should make no assumptions about the beliefs or commitments of any reader; contain nothing which might imply that one individual is superior to another on the grounds of age, gender, race, ethnicity, culture, sexual orientation, disability or health condition; and use inclusive language throughout. Authors should ensure that writing is free from bias, stereotypes, slang, reference to dominant culture and/or cultural assumptions. We advise to seek gender neutrality by using plural nouns ("clinicians, patients/clients") as default/wherever possible to avoid using "he, she," or "he/she." We recommend avoiding the use of descriptors that refer to personal attributes such as age, gender, race, ethnicity, culture, sexual orientation, disability or health condition unless they are relevant and valid. These guidelines are meant as a point of reference to help identify appropriate language but are by no means exhaustive or definitive.
Author Contributions
Authors are required to identify the contributions for which they are responsible. The author responsible for the integrity of the entire study should be identified. Please list the following phrases and beside each indicate the name(s) of the author(s) to whom they apply:
1 guarantor of integrity of the entire study
2 study concepts and design
3 literature research
4 clinical studies
5 experimental studies / data analysis
6 statistical analysis
7 manuscript preparation
8 manuscript editing
Items that do not apply should also be indicated with N/A. Where there is any uncertainty regarding authorship the editor of the study reserves the right to contact the guarantor of the study for further information.
Authorship
All authors should have made substantial contributions to all of the following: (1) the conception and design of the study, or acquisition of data, or analysis and interpretation of data, (2) drafting the article or revising it critically for important intellectual content, (3) final approval of the version to be submitted.
Changes to authorship
Authors are expected to consider carefully the list and order of authors before submitting their manuscript and provide the definitive list of authors at the time of the original submission. Any addition, deletion or rearrangement of author names in the authorship list should be made only before the manuscript has been accepted and only if approved by the journal Editor. To request such a change, the Editor must receive the following from the corresponding author: (a) the reason for the change in author list and (b) written confirmation (e-mail, letter) from all authors that they agree with the addition, removal or rearrangement. In the case of addition or removal of authors, this includes confirmation from the author being added or removed.
Only in exceptional circumstances will the Editor consider the addition, deletion or rearrangement of authors after the manuscript has been accepted. While the Editor considers the request, publication of the manuscript will be suspended. If the manuscript has already been published in an online issue, any requests approved by the Editor will result in a corrigendum.
Reporting clinical trials
Randomized controlled trials should be presented according to the CONSORT guidelines. At manuscript submission, authors must provide the CONSORT checklist accompanied by a flow diagram that illustrates the progress of patients through the trial, including recruitment, enrollment, randomization, withdrawal and completion, and a detailed description of the randomization procedure. The CONSORT checklist and template flow diagram are available online.
Registration of clinical trials
Registration in a public trials registry is a condition for publication of clinical trials in this journal in accordance with International Committee of Medical Journal Editors recommendations. Trials must register at or before the onset of patient enrolment. The clinical trial registration number should be included at the end of the abstract of the article. A clinical trial is defined as any research study that prospectively assigns human participants or groups of humans to one or more health-related interventions to evaluate the effects of health outcomes. Health-related interventions include any intervention used to modify a biomedical or health-related outcome (for example drugs, surgical procedures, devices, behavioural treatments, dietary interventions, and process-of-care changes). Health outcomes include any biomedical or health-related measures obtained in patients or participants, including pharmacokinetic measures and adverse events. Purely observational studies (those in which the assignment of the medical intervention is not at the discretion of the investigator) will not require registration.
Copyright
Upon acceptance of an article, authors will be asked to complete a 'Journal Publishing Agreement' (see more information on this). An e-mail will be sent to the corresponding author confirming receipt of the manuscript together with a 'Journal Publishing Agreement' form or a link to the online version of this agreement.
Subscribers may reproduce tables of contents or prepare lists of articles including abstracts for internal circulation within their institutions. Permission of the Publisher is required for resale or distribution outside the institution and for all other derivative works, including compilations and translations. If excerpts from other copyrighted works are included, the author(s) must obtain written permission from the copyright owners and credit the source(s) in the article. Elsevier has preprinted forms for use by authors in these cases.
Author rights
As an author you (or your employer or institution) have certain rights to reuse your work. More information.
Elsevier supports responsible sharing
Find out how you can share your research published in Elsevier journals.
Role of the funding source
You are requested to identify who provided financial support for the conduct of the research and/or preparation of the article and to briefly describe the role of the sponsor(s), if any, in study design; in the collection, analysis and interpretation of data; in the writing of the report; and in the decision to submit the article for publication. If the funding source(s) had no such involvement then this should be stated.
Open access
Please visit our Open Access page for more information.
Language (usage and editing services)
Please write your text in good English (American or British usage is accepted, but not a mixture of these). Authors who feel their English language manuscript may require editing to eliminate possible grammatical or spelling errors and to conform to correct scientific English may wish to use the English Language Editing service available from Elsevier's Author Services.
Submission
Our online submission system guides you stepwise through the process of entering your article details and uploading your files. The system converts your article files to a single PDF file used in the peer-review process. Editable files (e.g., Word, LaTeX) are required to typeset your article for final publication. All correspondence, including notification of the Editor's decision and requests for revision, is sent by e-mail.
Submit your article
Please submit your article via https://www.editorialmanager.com/yclon.
……
更多详情：
https://www.elsevier.com/journals/clinical-oncology/0936-6555/guide-for-authors
